- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- December 2024
- 200 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- May 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- May 2024
- 174 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- July 2024
- 185 Pages
Global
From €2386EUR$2,500USD£1,999GBP
- Report
- May 2024
- 185 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- April 2024
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- July 2024
- 200 Pages
Global
From €4723EUR$4,949USD£3,957GBP
- Report
- June 2024
- 200 Pages
Global
From €4767EUR$4,995USD£3,994GBP
- Report
- May 2024
- 70 Pages
United States
From €4724EUR$4,950USD£3,958GBP
- Report
- September 2021
- 150 Pages
Global
From €4580EUR$4,799USD£3,837GBP
- Report
- March 2025
Global
From €300EUR$337USD£260GBP
- Report
- November 2021
- 222 Pages
Global
From €2863EUR$3,000USD£2,399GBP
- Report
- October 2023
- 85 Pages
United States
From €4629EUR$4,850USD£3,878GBP
- Report
- May 2022
- 196 Pages
Global
From €2505EUR$2,625USD£2,099GBP
€5010EUR$5,250USD£4,198GBP
- Report
- August 2023
- 250 Pages
Global
From €2376EUR$2,490USD£1,991GBP
- Report
- October 2022
- 270 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- August 2022
- 222 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- September 2022
- 232 Pages
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- May 2022
- 190 Pages
Global
From €3340EUR$3,500USD£2,799GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more